Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole as Early Adjuvant Treatment in Postmenopausal Breast Cancer
NCT00332852Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2006
- Primary completion
- Jul 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of letrozole in breast cancer, sponsored by Novartis. Started Mar 2006; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00332852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332852.